Safety and efficacy of Lodoxamide in vernal keratoconjunctivitis

Journal of the Pakistan Medical Association

Volumn 61, Issue 3, 2011, Pages 239-241

  Das, Dial ^a   Khan, Moosa ^a   Gul, Ali ^a   Alam, Raffique ^b  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Lodoxamide; Vernal keratoconjunctivitis

Indexed keywords

LODOXAMIDE;

ADOLESCENT; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EYE BURNING; EYE DISCOMFORT; EYE EDEMA; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR FOREIGN BODY; MALE; OPHTHALMOLOGY; OUTPATIENT DEPARTMENT; PAKISTAN; SLIT LAMP; SYMPTOMATOLOGY; VERNAL CONJUNCTIVITIS;

ADMINISTRATION, TOPICAL; ADULT; ANTI-ALLERGIC AGENTS; CONJUNCTIVITIS, ALLERGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OPHTHALMIC SOLUTIONS; OXAMIC ACID; TREATMENT OUTCOME;

EID: 79952203058     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Shoja MR, Besharati MR. Evaluation of keratoconus by videokeratography in subjects with vernal keratoconjunctivitis (VKC). J Res Med Sci 2006; 11: 164-9.
2. Attarzadeh A, Khalili MR, Mosallaei M. The Potential Therapeutic Effect of Green Tea in Treatment of Vernal Keratoconjunctivitis. Irn J Med Hypotheses Ideas 2008; 2: 21.
3. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Reti Eye Res 2002; 21: 319-39.
4. McGill J, Holgate S, Church M, Anderson D, Bacon A. Allergic eye disease mechanisms. Br J Ophthalmol 1998; 82: 1203-14.
5. Freeman N. Vernal keratoconjunctivitis. Curr Aller Clin Immunol 2006; 19: 60-3.
6. Kawuma M. The clinical picture of vernal keratoconjunctivitis in Uganda. Community Eye Health 2001; 14: 66-7.
7. Pucci N, Novembre E, Lombardi E, Massai C, Bernardini R, Caputo R, et al. Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis. Pediatrics 2005; 115: e86-91.
8. Ali SS, Ansari MZ and Sharif-ul-Hasan K. Featurs of vernal kerato conjunctivitis in a rural population of Karachi. Pak J Ophthalmol 2006; 22: 174-7.
9. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye (Lond) 2004; 18: 345-51.
10. Jay JL. Clinical features and diagnosis of adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthalmol 1981; 65: 335-40.
11. Montan PG, Ekstrom K, Hedlin G, van Hage-Hamsten M, Hjern A, Herrmann B. Vernal keratoconjunctivitis in a Stockholm ophthalmic centre - epidemiological, functional and immunologic investigations. Acta Ophthalmol Scand 1999; 77: 559-63.
12. Schmid KL, Schmid LM. Ocular allergy: causes and therapeutic options. Clin Exp Optom 2000; 83: 257-70.
13. Tabbara KF, Arafat NT. Cromolyn effects on vernal keratoconjunctivitis in children. Arch Ophthalmol 1977; 95: 2184-6.
14. Meyer D. Current concepts in the therapeutic approach to allergic conjunctivitis. Current Allergy Clin Immunol 2006; 19: 65-8.
15. Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, et al. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmol 1997; 104: 849-53.
16. Avunduk AM, Avunduk MC, Kapicioglu Z, Akyal N, Tavli L. Mechanism and comparison of anti-allergic efficacy of topical lodoxamide and Cromolyn sodium treatment in vernal keratoconjunctivitis. Ophthalmology 2000; 107: 1333-7.